FDA Chief: Slow Agency Review Process is Urban Mythology

During March 13 testimony before a Senate committee, Food and Drug Administration Commissioner Margaret Hamburg, M.D., defended the length of time it takes the regulatory agency to review and approve medical devices. "I can assure you that the FDA review teams take their job very, very seriously, going through in a systematic way the data that's available to them, assessing safety, efficacy and overall risks and benefits to patients," Hamburg testified.

Get access to this article and thousands more...

All Health Data Management articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts, e-books, and conference discounts. Qualified members may also choose to receive our free monthly magazine and any of our e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and specialized topics like EHR's, revenue cycle management, health insurance exchanges, analytics, and more!

Already Registered?

Forgot Password/Need Help?
Comments (0)

Be the first to comment on this post using the section below.

Add Your Comments:
Not Registered?
You must be registered to post a comment. Click here to register.
Already registered? Log in here
Please note you must now log in with your email address and password.


Slide Shows

Already a subscriber? Log in here
Please note you must now log in with your email address and password.